Journal of Neuroimmune Pharmacology

, Volume 9, Issue 2, pp 195–208

Animal Models for Depression Associated with HIV-1 Infection

  • Isabella Cristina Gomes Barreto
  • Patricia Viegas
  • Edward B. Ziff
  • Elisabete Castelon Konkiewitz
INVITED REVIEW

DOI: 10.1007/s11481-013-9518-9

Cite this article as:
Barreto, I.C.G., Viegas, P., Ziff, E.B. et al. J Neuroimmune Pharmacol (2014) 9: 195. doi:10.1007/s11481-013-9518-9

Abstract

Antiretroviral therapy has greatly extended the lifespan of people living with human immunodeficiency virus (PLHIV). As a result, the long-term effects of HIV infection, in particular those originating in the central nervous system (CNS), such as HIV associated depression, have gained importance. Animal models for HIV infection have proved very useful for understanding the disease and developing treatment strategies. However, HIV associated depression remains poorly understood and so far there is neither a fully satisfactory animal model, nor a pathophysiologically guided treatment for this condition. Here we review the neuroimmunological, neuroendocrine, neurotoxic and neurodegenerative basis for HIV depression and discuss strategies for employing HIV animal models, in particular humanized mice which are susceptible to HIV infection, for the study of HIV depression.

Keywords

Human immunodeficiency virus-1 HIV-1 Animal model Transgenic rodents Humanized mice Depression gp120 Tat Cytokines Sickness behavior 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Isabella Cristina Gomes Barreto
    • 1
  • Patricia Viegas
    • 1
  • Edward B. Ziff
    • 2
  • Elisabete Castelon Konkiewitz
    • 1
  1. 1.Faculdade de Ciências da SaudeUniversidade Federal da Grande DouradosDouradosBrazil
  2. 2.Department of Biochemistry and Molecular PharmacologyNew York University School of MedicineNew YorkUSA

Personalised recommendations